On July 4, 2017, Nanjing BioPredia Medicine Co. , Ltd was formally established in Nanjing Jiangbei New Area Biomedicine Valley Zhongdan Ecological Life Science Industrial Park Phase I. As a wholly-owned subsidiary of BioPredia BioTech Co., Ltd. "Nanjing Biopredia Medicine Co. , Ltd " is a domestic-funded enterprise with its registered address at Room 2102-2104, Building B, Zhongdan Ecological Life Science Industrial Park, No. 3-1, Xinjinhu Road, Nanjing High-tech Development Zone, with a registered capital of 5 million yuan. The scope of business is: Technology development, technical services, technical consulting, technology transfer and production and sales of related products in the field of biomedicine. Specifically undertake the research and development, clinical trials, registration, and product sales of in vitro diagnostic kit products. Tao Wenjing is the legal representative, executive director and general manager of the company.
      The Sino-Denmark Ecological Life Science Industrial Park, where the company is located, has a planned area of about 300 acres. It is the first ecological life science park in China to be jointly built with Denmark. It integrates with advanced parks and advanced enterprises in Denmark, comprehensively improves policy support, economic support, supporting services and comprehensive management capabilities, vigorously develops biotechnology, energy conservation and environmental protection and other life science industries, and jointly builds a characteristic technology "park in the park". The first phase of the Zhongdan Park R&D Building covers an area of 33 mu, with a total construction area of 95,500 square meters. At present, dozens of companies have settled in Israel ADAMA China R&D Center, Nanjing High-tech Biomedical Public Service Platform, Jiangsu Subo Biomedical Technology Nanjing Co., Ltd. and other companies.